Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
to uncover new molecular strategies for safeguarding crops. Join a vibrant, interdisciplinary research environment where computational chemistry, biochemistry, molecular biology, and plant science converge
-
interactions to uncover new molecular strategies for safeguarding crops. Join a vibrant, interdisciplinary research environment where computational chemistry, biochemistry, molecular biology, and plant science
-
set a course for the future – a future that you can help to shape. The EMAT research group at the Faculty of Science (University of Antwerp) is seeking to fill a PhD position on the development
-
. This exciting project is funded by a Industry PhD Program. Flinders University and Bookbot.com, are partners in the program. The student will be based at Flinders University for 4 days a week. The candidate will
-
cycles and refine deliverables accordingly. The skills, qualifications and experience required to perform the role are: A PhD in Computer Science, Civil Engineering, Data Science, Information Systems, or a
-
£20,780 per year, and includes a 3-month fusion engineering CDT training programme as part of the 2025 Cohort. This project is co-supervised by Dr Chris Hardie from UKAEA. The UoB Materials for eXtremes
-
July 9th 2025; interview of shortlisted candidate to occur July 17th- 18th. Informal enquiries can be directed to mcelherm@tcd.ie (Dr Matt McElheron; computational biology lead) and nbourke@tcd.ie (Prof
-
£20,780 per year, and includes a 3-month fusion engineering CDT training programme as part of the 2026 Cohort. This project is co-supervised by Dr Chris Hardie from UKAEA. The UoB Materials for eXtremes
-
field” imaging techniques to solve many important problems in biology and change clinical practice in respiratory medicine. Our ongoing research program involves developing new imaging technologies
-
treatment and improved clinical outcomes. The supervisory team of Dr. Paul Facey, Dr. Claire Morgan and Prof. Dean Harris, bringing expertise in cancer genomics, microbiology, and clinical translation